top of page

Multiple Myeloma Disease Overview

Thu, Jul 16

|

Webcast

Speaker: ANN MCNEILL, RN, MSN, APN, NP Multiple Myeloma Division John Theurer Cancer Center at HUMC

Registration is Closed
See other events
Multiple Myeloma Disease Overview
Multiple Myeloma Disease Overview

Time & Location

Jul 16, 2020, 12:00 PM

Webcast

Guests

About The Event

Presented via Webcast

Thursday, July 16, 2020 12:00 PM Eastern

Please RSVP to:

Gwen Altman Phone: (508) 330-2416 E-mail: gwena@amgen.com

Notice: Thisevent is conducted in accordance with the PhRMA Code on Interaction with Healthcare Professionals and is limited to invited healthcare professionals.Attendancebyguestsorspouseisnotappropriate.Governmentemployeesare subject to state and federal laws and ethics rules that may limit your ability to receive any gifts , including meals, from pharmaceutical companies. If you are a state or federal employee, it is your responsibility to seek guidance and prior approval from your employer or site ethics counselor to attend this event.

State Laws: To comply with law and Amgen policies, Amgen is unable to offer food and beverages to (1) individuals with prescribing authority in Vermont or Minnesota; or (2) individuals employed by prescribers in Vermont who s upport the provision of healthcare. Please confirm the value of the meal with your Amgen representative before accepting the meal.You have the opportunity to opt-out of the meal and/or purchase your own meal, if applicable. Please note that Amgen exercises diligence in reviewing the licensure of attendees and asks that you cooperate by disclosing all licensures in the sign- in/registration process. We appreciate your understanding and support.

Disclosure by Amgen: Amgen reports payments and transfers of value made to healthcare professionals and other healthcare related entities in accordance with federal and state laws, regulations and other transparency obligations. Any items of value provided by Amgen at this event (including the provision of meals and refreshments) maybe subject to public disclosure. If you have questions regarding this matter please contact Amgen at 805-447-7422 or HCCSpendInquiry@amgen.com.

Share This Event

bottom of page